tiprankstipranks
Inmed Pharmaceuticals Inc. (DE:MWG)
:MWG
Germany Market

InMed Pharmaceuticals (MWG) Ownership - Who Owns InMed Pharmaceuticals?

Compare
1 Followers

InMed Pharmaceuticals (MWG) Ownership Overview

32.04%3.19%2.36%62.41%
32.04% Insiders
3.19% Other Institutional Investors
2.36% ETFs
62.41% Public Companies and Individual Investors
The ownership structure of InMed Pharmaceuticals (DE:MWG) stock is a mix of institutional, retail, and individual investors. , 32.04% is owned by Insiders, and 62.41% is owned by Public Companies and Individual Investors.
The ownership structure of InMed Pharmaceuticals (DE:MWG) stock is a mix of institutional, retail, and individual investors. Approximately 5.54% of the company’s stock is owned by Institutional Investors, 32.04% is owned by Insiders, and 62.41% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 02, 2024
xxxxxxxxxxxxx
$41

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
304,595Insider25.23%933,584
43,959Insider3.64%134,734
38,258Insider3.17%117,261
28,460Institution2.36%87,230

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Inmed Pharmaceuticals Inc. (DE:MWG)?
According to the latest TipRanks data, approximately 3.19% of the company's stock is held by institutional investors, 32.04% is held by insiders, and 62.41% is held by retail investors.
    What percentage of Inmed Pharmaceuticals Inc. (DE:MWG) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 3.19% of Inmed Pharmaceuticals Inc. (DE:MWG) stock is held by institutional investors.
      What percentage of Inmed Pharmaceuticals Inc. (DE:MWG) stock is held by retail investors?
      According to the latest TipRanks data, approximately 62.41% of Inmed Pharmaceuticals Inc. (DE:MWG) stock is held by retail investors.
        Who owns the most shares of Inmed Pharmaceuticals Inc. (DE:MWG)?
        Shane Aaron Johnson owns the most shares of Inmed Pharmaceuticals Inc. (DE:MWG).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis